gms | German Medical Science

70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

12.05. - 15.05.2019, Würzburg

Vorträge Dienstag, 14.05.2019
Gliome klinisch/Gliomas clinical

Meeting Abstract (V120)

Contemporary outcome of low grade glioma surgery – results of a prospective multicenter series from the LoG-Glio registry

Coburger J, Roder C, Nadji-Ohl M, Rückriegel S, von der Brelie C, Faust K, Löbel F, Schommer S, Löhr M, Grübel N, Vajcoczy P, Rohde V, Ernestus RI, Ganslandt O, Tatagiba M, Wirtz CR, Pala A
Meeting Abstract (V121)

Is less more? Comparison of wait and scan with primary adjuvant treatments in IDH mutant low grade gliomas

Coburger J, Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Scheuerle A, Senft C, Tatagiba M, Synowitz M, Schmitz B, Wirtz CR, Unterberg AW, Pala A
Meeting Abstract (V122)

Continuous volmetric impact of surgery on survival in low-grade gliomas – a retrospective multicentre assessment from the German study-group for intraoperative MRI

Scherer M, Ahmeti H, Roder C, Geßler F, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Unterberg AW, Coburger J
Meeting Abstract (V123)

Complete resection of biological tumor volume in 18F-FET-PET correlates with better overall survival in WHO grade III and grade IV glioma

Hamou H, Tan S, Langen KJ, Neuloh G, Clusmann H, Delev D
Meeting Abstract (V124)

Complete versus incomplete resection in newly diagnosed glioblastoma – impact on functional outcome

Haj A, Doenitz C, Schebesch KM, Brawanski A, Proescholdt M
Meeting Abstract (V125)

Bevacizumab improves functional status and focal neurological deficits in patients with recurrent glioblastoma

Falter J, Rotter B, Brawanski A, Bumes E, Hau P, Proescholdt M
Meeting Abstract (V126)

Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma

Thon N, Fleischmann D, Tonn JC, Kreth FW, Belka C, Niyazi KM
Meeting Abstract (V127)

Influence of individual CpG methylation status on outcome in adult patients with glioblastoma multiforme receiving alkylating agent treatment

Siller S, Lauseker M, Giese A, Tonn JC, Niyazi KM, Thon N, Suchorska B, Kreth FW
Meeting Abstract (V128)

Central nervous system tumour patients have elevated levels of circulating extracellular vesicles

Ricklefs FL, Maire C, Kolbe K, Holz M, Reimer R, Glatzel M, Chiocca EA, Westphal M, Lamszus K
Meeting Abstract (V129)

MiRNA-181d expression significantly affects treatment responses to carmustine wafer implantation in glioblastoma patients

Sippl C, Ketter R, Urbschat S, Kim YJ, Bohr L, Oertel J
Meeting Abstract (V130)

Retrospective evaluation of age as an influencing factor for survival in patients with malignant gliomas

Berger K, Mijderwijk HJ, Turowski B, Steiger HJ, Rapp M, Sabel M, Kamp MA
Meeting Abstract (V131)

Re-Resection in elderly glioblastoma patients – a reasonable treatment option?

Farina Nunez M, Franco P, Beck J, Heiland DH, Schnell O